AI-generated content for informational purposes only. Not financial advice. Always do your own research.

关于

Global infrastructure consulting firm delivering professional services across transportation, water, government, and environmental sectors. Designs and manages major infrastructure projects worldwide.

建筑与材料股票

AECOM 是全球基础设施咨询领导者,为运输、水务和环保部门的主要建筑项目提供设计和咨询服务。

基础设施股票

AECOM 在全球范围内提供专业基础设施服务,受益于运输、水务和环保基础设施的持续政府和私人投资。

Key Financials ACM

价格 $88.31
变化(1天) -0.08%
变化 (30D) -7.36%
变化 (60D) -33.06%
变化 (90D) -31.82%
变化 (180D) -18.34%
变化 (1Y) -14.91%
变化 (5Y) +65.03%
P/E比率 20.78
EPS (TTM) $4.25
52周区间 $85.00 — $135.52
50日MA $98.15
成交量 3.34M

Data updated Feb 15 · Source: Twelve Data

3.7
1 reviews
Fundamentals
4
Management Quality
4
Valuation
3.6
Performance
3.4
Risk Profile
3.2
Claude Opus 4.6
AI Review
3.7/5

AECOM is a global infrastructure consulting firm with leading positions in transportation, water, environment, and facilities design. The company has successfully transformed itself by divesting lower-margin construction services to focus on its higher-margin professional services business, improving profitability and cash flow predictability.

The bull case centers on secular tailwinds from the U.S. Infrastructure Investment and Jobs Act, growing demand for climate resilience projects, and AECOM's strong backlog providing revenue visibility. Its asset-light model generates solid free cash flow supporting buybacks and debt reduction.

However, the stock has experienced a sharp correction, down 33% over 60 days and trading well below its 50-day moving average of $98.15, now near its 52-week low of $85. This decline likely reflects broader market concerns about government spending cuts and potential project delays. The P/E of 20.78x is reasonable for the sector but leaves limited margin of safety if earnings disappoint.

The bear case includes exposure to government budget uncertainty, potential infrastructure spending slowdowns, and macroeconomic sensitivity. While the selloff may present a value opportunity for patient investors, near-term momentum remains decidedly negative. Wait for stabilization before adding.

Fundamentals
4
Management Quality
4
Valuation
3.6
Performance
3.4
Risk Profile
3.2
Feb 15, 2026